东方生物: 第三届监事会第十二次会议决议公告

Group 1 - The company plans to repurchase its shares using an amount not less than RMB 25 million and not exceeding RMB 50 million through centralized bidding within a period of up to 3 months from the board's approval of the repurchase plan [2][1] - The repurchase is in compliance with relevant laws and regulations, including the "Regulations on the Repurchase of Shares by Listed Companies" and the "Self-Regulatory Guidelines for Listed Companies No. 7 - Share Repurchase" [2][1] - The supervisory board has confirmed that the repurchase plan is in the interest of all shareholders, particularly minority shareholders, and that the decision-making process is legal and compliant [2][1]